Publication Cover
Inhalation Toxicology
International Forum for Respiratory Research
Volume 34, 2022 - Issue 1-2
2,058
Views
1
CrossRef citations to date
0
Altmetric
Research Articles

Pulmonary translocation of ultrafine carbon particles in COPD and IPF patients

, , , &
Pages 14-23 | Received 18 Mar 2021, Accepted 18 Nov 2021, Published online: 30 Dec 2021

References

  • Ahluwalia N, Shea BS, Tager AM. 2014. New therapeutic targets in idiopathic pulmonary fibrosis. Aiming to rein in runaway wound-healing responses. Am J Respir Crit Care Med. 190(8):867–878.
  • Atkinson RW, Kang S, Anderson HR, Mills IC, Walton HA. 2014. Epidemiological time series studies of PM2. 5 and daily mortality and hospital admissions: a systematic review and meta-analysis. Thorax. 69(7):660–665.
  • Beelen R, Stafoggia M, Raaschou-Nielsen O, Andersen ZJ, Xun WW, Katsouyanni K, Dimakopoulou K, Brunekreef B, Weinmayr G, Hoffmann B, et al. 2014. Long-term exposure to air pollution and cardiovascular mortality: an analysis of 22 European cohorts. Epidemiology. 25(3):368–378.
  • Brådvik I, Wollmer P, Evander E, Lárusdóttir H, Blom-Bulow B, Jonson B. 2002. Kinetics of lung clearance of 99mTc-DTPA in smoking patients with sarcoidosis compared to healthy smokers. Respir Med. 96(5):317–321.
  • Brook RD, Newby DE, Rajagopalan S. 2018. Air pollution and cardiometabolic disease: an update and call for clinical trials. Am J Hypertension. 31(1):1–10.
  • Brook RD, Rajagopalan S, Pope CA, Brook JR, Bhatnagar A, Diez-Roux AV, Holguin F, Hong Y, Luepker RV, Mittleman MA, et al. 2010. Particulate matter air pollution and cardiovascular disease. Circulation. 121(21):2331–2378.
  • Brown JS, Zeman KL, Bennett WD. 2002. Ultrafine particle deposition and clearance in the healthy and obstructed lung. Am J Respir Crit Care Med. 166(9):1240–1247.
  • Burton NC, Grinshpun SA, Reponen T. 2007. Physical collection efficiency of filter materials for bacteria and viruses. Ann Occup Hyg. 51(2):143–151.
  • Chilosi M, Poletti V, Rossi A. 2012. The pathogenesis of COPD and IPF: distinct horns of the same devil? Respir Res. 13(1):3.
  • Choi CH, Zuckerman JE, Webster P, Davis ME. 2011. Targeting kidney mesangium by nanoparticles of defined size. Proc Natl Acad Sci USA. 108(16):6656–6661.
  • Cosio MG, Saetta M, Agusti A. 2009. Immunologic aspects of chronic obstructive pulmonary disease. N Engl J Med. 360(23):2445–2454.
  • Currie LA. 1968. Limits for qualitative detection and quantification determination. Anal Chem. 40(3):586–593.
  • Demedts IK, Demoor T, Bracke KR, Joos GF, Brusselle GG. 2006. Role of apoptosis in the pathogenesis of COPD and pulmonary emphysema. Respir Res. 7:53.
  • DI Stefano A, Capelli A, Lusuardi M, Balbo P, Vecchio C, Maestrelli P, Mapp CE, Fabbri LM, Donner CF, Saetta M, et al. 1998. Severity of airflow limitation is associated with severity of airway inflammation in smokers. Am J Respir Crit Care Med. 158(4):1277–1285.
  • Donaldson K, Stone V, Clouter A, Renwick L, MacNee W. 2001. Ultrafine particles. Occup Environ Med. 58(3):211–216.
  • Elder A, Gelein R, Silva V, Feikert T, Opanashuk L, Carter J, Potter R, Maynard A, Ito Y, Finkelstein J, et al. 2006. Translocation of inhaled ultrafine manganese oxide particles to the central nervous system. Environ Health Perspect. 114(8):1172–1178.
  • Geiser M, Casaulta M, Kupferschmid B, Schulz H, Semmler-Behnke M, Kreyling W. 2008. The role of macrophages in the clearance of inhaled ultrafine titanium dioxide particles. Am J Respir Cell Mol Biol. 38(3):371–376.
  • Geiser M, Kreyling WG. 2010. Deposition and biokinetics of inhaled nanoparticles. Part Fibre Toxicol. 7:2.
  • Ghio AJ, Bennett WD. 2007. Metal particles are inappropriate for testing a postulate of extrapulmonary transport. Environ Health Perspect. 115(2):A70.
  • Hedenstrom H, Malmberg P, Agarwal K. 1985. Reference values for lung function tests in females. Regression equations with smoking variables. Bull Eur Physiopathol Respir. 21(6):551–557.
  • Hedenstrom H, Malmberg P, Fridriksson HV. 1986. Reference values for lung function tests in men: regression equations with smoking variables. Ups J Med Sci. 91(3):299–310.
  • Huang HL, Huang YC, Wang DM. 2004. Aerosol filtration efficiency of Teflon fibrous filters. J Aerosol Sci. 35:S973–S974.
  • Klepczyńska-Nyström A, Sanchez-Crespo A, Andersson M, Falk R, Lundin A, Larsson B-M, Svartengren M. 2012. The pulmonary deposition and retention of indium-111 labeled ultrafine carbon particles in healthy individuals. Inhal Toxicol. 24(10):645–651.
  • Kreyling WG, Semmler M, Erbe F, Mayer P, Takenaka S, Schulz H, Oberdörster G, Ziesenis A. 2002. Translocation of ultrafine insoluble iridium particles from lung epithelium to extrapulmonary organs is size dependent but very low. J Toxicol Environ Health A. 65(20):1513–1530.
  • Kreyling WG, Semmler-Behnke M, Seitz J, Scymczak W, Wenk A, Mayer P, Takenaka S, Oberdörster G. 2009. Size dependence of the translocation of inhaled iridium and carbon nanoparticle aggregates from the lung of rats to the blood and secondary target organs. Inhal Toxicol. 21(sup1):55–60.
  • Kuhn C, McDonald JA. 1991. The roles of the myofibroblast in idiopathic pulmonary fibrosis. Ultrastructural and immunohistochemical features of sites of active extracellular matrix synthesis. Am J Pathol. 138(5):1257–1265.
  • Lundborg M, Dahlén SE, Johard U, Gerde P, Jarstrand C, Camner P, Låstbom L. 2006. Aggregates of ultrafine particles impair phagocytosis of microorganisms by human alveolar macrophages. Environ Res. 100(2):197–204.
  • Miller MR, Raftis JB, Langrish JP, McLean SG, Samutrtai P, Connell SP, Wilson S, Vesey AT, Fokkens P, Boere A, et al. 2017. Inhaled nanoparticles accumulate at sites of vascular disease. ACS Nano. 11(5):4542–4552.
  • Mills IC, Atkinson RW, Kang S, Walton H, Anderson HJBo. 2015. Quantitative systematic review of the associations between short-term exposure to nitrogen dioxide and mortality and hospital admissions. BMJ Open. 5(5):e006946–e006946.
  • Mills NL, Törnqvist H, Gonzalez MC, Vink E, Robinson SD, Söderberg S, Boon NA, Donaldson K, Sandström T, Blomberg A, et al. 2007. Ischemic and thrombotic effects of dilute diesel-exhaust inhalation in men with coronary heart disease. N Engl J Med. 357(11):1075–1082.
  • Möller W, Felten K, Sommerer K, Scheuch G, Meyer G, Meyer P, Häussinger K, Kreyling WG. 2008. Deposition, retention, and translocation of ultrafine particles from the central airways and lung periphery. Am J Respir Crit Care Med. 177(4):426–432.
  • Nemmar A, Hoet PHM, Vanquickenborne B, Dinsdale D, Thomeer M, Hoylaerts MF, Vanbilloen H, Mortelmans L, Nemery B. 2002. Passage of inhaled particles into the blood circulation in humans. Circulation. 105(4):411–414.
  • Newby DE, Mannucci PM, Tell GS, Baccarelli AA, Brook RD, Donaldson K, Forastiere F, Franchini M, Franco OH, Graham I, ESC Heart Failure Association, et al. 2015. Expert position paper on air pollution and cardiovascular disease. Eur Heart J. 36(2):83–93.
  • Oberdörster G, Sharp Z, Atudorei V, Elder A, Gelein R, Kreyling W, Cox C. 2004. Translocation of inhaled ultrafine particles to the brain. Inhal Toxicol. 16(6–7):437–445.
  • Oberdörster G, Sharp Z, Atudorei V, Elder A, Gelein R, Lunts A, Kreyling W, Cox C. 2002. Extrapulmonary translocation of ultrafine carbon particles following whole-body inhalation exposure of rats. J Toxicol Environ Health A. 65(20):1531–1543.
  • Raghu G, Anstrom KJ, King TE, Jr., Lasky JA, Martinez FJ. 2012. Prednisone, azathioprine, and N-acetylcysteine for pulmonary fibrosis. N Engl J Med. 366(21):1968–1977.
  • Raghu G, Remy-Jardin M, Myers JL, Richeldi L, Ryerson CJ, Lederer DJ, Behr J, Cottin V, Danoff SK, Morell F, American Thoracic Society, European Respiratory Society, Japanese Respiratory Society, and Latin American Thoracic Society, et al. 2018. Diagnosis of idiopathic pulmonary fibrosis. An official ATS/ERS/JRS/ALAT clinical practice guideline. Am J Respir Crit Care Med. 198(5):e44–e68.
  • Renwick LC, Donaldson K, Clouter A. 2001. Impairment of alveolar macrophage phagocytosis by ultrafine particles. Toxicol Appl Pharmacol. 172(2):119–127.
  • Rinderknecht J, Shapiro L, Krauthammer M, Taplin G, Wasserman K, Uszler JM, Effros RM. 1980. Accelerated clearance of small solutes from the lungs in interstitial lung disease. Am Rev Respir Dis. 121(1):105–117.
  • Rosenlund M, Berglind N, Pershagen G, Hallqvist J, Jonson T, Bellander T. 2006. Long-term exposure to urban air pollution and myocardial infarction. Epidemiology. 17(4):383–390.
  • Saenen ND, Bové H, Steuwe C, Roeffaers MBJ, Provost EB, Lefebvre W, Vanpoucke C, Ameloot M, Nawrot TS. 2017. Children's urinary environmental carbon load. A novel marker reflecting residential ambient air pollution exposure? Am J Respir Crit Care Med. 196(7):873–881.
  • Sanchez-Crespo A, Klepczynska-Nystrom A, Lundin A, Larsson BM, Svartengren M. 2011. 111Indium-labeled ultrafine carbon particles; a novel aerosol for pulmonary deposition and retention studies. Inhal Toxicol. 23(3):121–128.
  • Semmler M, Seitz J, Erbe F, Mayer P, Heyder J, Oberdörster G, Kreyling WG. 2004. Long-term clearance kinetics of inhaled ultrafine insoluble iridium particles from the rat lung, including transient translocation into secondary organs. Inhal Toxicol. 16(6-7):453–459.
  • Singh D, Agusti A, Anzueto A, Barnes PJ, Bourbeau J, Celli BR, Criner GJ, Frith P, Halpin DMG, Han M, et al. 2019. Global strategy for the diagnosis, management, and prevention of chronic obstructive lung disease: the GOLD science committee report 2019. Eur Respir J. 53(5):1900164.
  • Takenaka S, Karg E, Kreyling WG, Lentner B, Möller W, Behnke-Semmler M, Jennen L, Walch A, Michalke B, Schramel P, et al. 2006. Distribution pattern of inhaled ultrafine gold particles in the rat lung. Inhal Toxicol. 18(10):733–740.
  • Takenaka S, Karg E, Roth C, Schulz H, Ziesenis A, Heinzmann U, Schramel P, Heyder J. 2001. Pulmonary and systemic distribution of inhaled ultrafine silver particles in rats. Environ Health Perspect. 109(Suppl 4):547–551.
  • Wiebert P, Sanchez-Crespo A, Falk R, Philipson K, Lundin A, Larsson S, Möller W, Kreyling WG, Svartengren M. 2006. No significant translocation of inhaled 35-nm carbon particles to the circulation in humans. Inhal Toxicol. 18(10):741–747.
  • Wiebert P, Sanchez-Crespo A, Seitz J, Falk R, Philipson K, Kreyling WG, Möller W, Sommerer K, Larsson S, Svartengren M. 2006. Negligible clearance of ultrafine particles retained in healthy and affected human lungs. Eur Respir J. 28(2):286–290.
  • Wollmer P, Evander E. 1994. Biphasic pulmonary clearance of 99mTc-DTPA in smokers. Clin Physiol. 14(5):547–559.
  • World Health Organization. 2016. Ambient air pollution: a global assessment of exposure and burden of disease. World Health Organization. https://apps.who.int/iris/handle/10665/250141.
  • Wynn TA, Vannella KM. 2016. Macrophages in tissue repair, regeneration, and fibrosis. Immunity. 44(3):450–462.